GL1X · GenesisL1 explorer

MolNFT v2 · #204651 · protein

8BB5: Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker

8BB5 · Elongin-B: “Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker”. X-ray diffraction at 2.2, 3 ligands (Q43, K, SCN), 4 pockets (best druggability 0.75). MolNFT v2 #204651 on GenesisL1: 3D structure…

3D structure of 8BB5: Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker (MolNFT v2 / PDB Bank)
3D structure of 8BB5: Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker (MolNFT v2 / PDB Bank)
PDB
8BB5
Type
protein
Length
650 residues
Chains
4
Method
x-ray diffraction
Authors
Kraemer, A., Doelle, A., Knapp, S., Structural Genomics Consortium (SGC)
Deposited
10/12/22
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.2
Source
Homo sapiens
Molecule
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; WD repeat-containing…
UniProt
Q15370, Q15369, P40337, P61964
Ligands
Q43, K, SCN
Pockets
4 · best druggability 0.75

Structure

x-ray diffraction · resolution 2.2 · 4 distinct chains · 16% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AElongin-Bprotein10421% helix, 38% strandQ15370
BElongin-Cprotein8549% helix, 15% strandQ15369
Cvon Hippel-Lindau disease tumor suppressorprotein15427% helix, 27% strandP40337
DWD repeat-containing protein 5protein3070% helix, 51% strandP61964

Ligands and binding sites

  • Q43 · ~{N}-[5-[4-[[4-[2-[[(2~{S})-3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-2-oxidanylidene-ethyl]phenyl]methylcarbamoyl]phenyl]-2-(4-methylpiperazin-1-yl)phenyl]-6-oxidanyl-4-(trifluoromethyl)pyridine-3-carboxamide · ligand · chains C, D
  • K · Potassium ion · metal · chains C
  • SCN · Thiocyanate ion · ion · 10 copies · chains A, C, D
  • EDO · 1,2-ethanediol · additive · 4 copies · chains C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17550.750.8072Q43, SCN
2520.530.8818EDO
31670.430.7523empty
4870.370.7516empty

Interfaces

4 interfaces between chains.

  • A–B · 1129 Ų buried · 15 hydrogen bonds · protein-protein
  • B–C · 1040 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 189 Ų buried · 0 hydrogen bonds · protein-protein
  • C–D · 103 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain C against A, TM-score 0.97
  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain A against A, TM-score 0.97
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.